OARSI Clinical Trial Guidelines are used by scientists, graduate students and clinical investigators worldwide and serve as the benchmark trial design.

Topical non-steroidal anti-inflammatory drugs (NSAIDs) were strongly recommended for individuals with Knee OA (Level 1A). For individuals with gastrointestinal ...

The purpose of this initiative is to update and expand upon prior Osteoarthritis Research Society International (OARSI) guidelines by developing patient- ...

There are recommendations covering five surgical modalities: total joint replacements, unicompartmental knee replacement, osteotomy and joint preserving ...

This statement updates the previous OARSI recommendations, incorporating literature published between January 2009 and March 2013, to scrutinize the safety and ...

22 февр. 2022 г. · The purpose of this study was to assess the quality of clinical trials published between 2010 and 2020 investigating intra-articular interventions in patients ...

These evidence-based consensus recommendations provide guidance to patients and practitioners on treatments applicable to all individuals with knee OA.

Acetaminophen (paracetamol) (up to 4g/day) can be an effective initial oral analgesic for treatment of mild to moderate pain in patients with knee or hip OA.

28 окт. 2020 г. · OARSI and ESCEO both recommend education, structured exercise and weight loss as core treatments, topical NSAIDs as first-line treatments and oral NSAIDs and ...

These guidelines are based on a comprehensive review of the current scientific evidence for each treatment's safety and effectiveness.